Peak exercise oxygen consumption in chronic heart failure: Toward efficient use in the individual patient

Cristina Opasich, Gian Domenico Pinna, Marco Bobbio, Massimo Sisti, Brunella Demichelis, Oreste Febo, Giovanni Forni, Roberto Riccardi, P. Giorgio Riccardi, Soccorso Capomolla, Franco Cobelli, Luigi Tavazzi

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Objectives. This study sought to 1) assess the short-, medium- and long- term prognostic power of peak oxygen consumption (V̇O2) in patients with heart failure; 2) verify the consistency of a nonmeasurable anaerobic threshold (AT) as a criterion of nonapplicability of peak V̇O2; 3) develop simple rules for the efficient use of peak V̇O2 in individualized prognostic stratification and clinical decision making. Background. Peak V̇O2, when AT is identified, is among the indicators for heart transplant eligibility. However, in clinical practice the application of defined peak V̇O2 cutoff values to all patients could be inappropriate and misleading. Methods. Six hundred fifty-three patients consecutively considered for eligibility for heart transplantation were followed up. Outcomes (cardiac death and urgent transplantation) were determined when all survivors had a minimum of 6 months of follow-up. Results. Contraindication to the exercise test identified very high risk patients. The relatively small sample of women did not allow inferences to be drawn. In men, peak V̇O2 stratified into three levels (≤10, 10 to 18 and >18 ml/kg per min) identified groups at high, medium and low risk, respectively. The prognostic power of peak V̇O2 ≤10 ml/kg per min was maintained even when the AT was not detected. In patients in New York Heart Association functional class III or IV, peak V̇O2 did not have prognostic power. In patients in functional class I or II, peak V̇O2 stratification was prognostically valuable, but less so at 6 than at 12 or 24 months. Age did not influence peak V̇O2 prognostic stratification. Conclusions. A contraindication to exercise testing should be considered a priority for listing patients for heart transplantation. Only in less symptomatic male patients does a peak V̇O2 ≤10 ml/kg per min identify short-, medium- and long-term high risk groups. A peak V̇O2 >18 ml/kg per min implies good prognosis with medical therapy.

Original languageEnglish
Pages (from-to)766-775
Number of pages10
JournalJournal of the American College of Cardiology
Volume31
Issue number4
DOIs
Publication statusPublished - Mar 15 1998

Fingerprint

Oxygen Consumption
Heart Failure
Exercise
Anaerobic Threshold
Heart Transplantation
Exercise Test
Survivors
Transplantation
Transplants

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Peak exercise oxygen consumption in chronic heart failure : Toward efficient use in the individual patient. / Opasich, Cristina; Pinna, Gian Domenico; Bobbio, Marco; Sisti, Massimo; Demichelis, Brunella; Febo, Oreste; Forni, Giovanni; Riccardi, Roberto; Riccardi, P. Giorgio; Capomolla, Soccorso; Cobelli, Franco; Tavazzi, Luigi.

In: Journal of the American College of Cardiology, Vol. 31, No. 4, 15.03.1998, p. 766-775.

Research output: Contribution to journalArticle

Opasich, C, Pinna, GD, Bobbio, M, Sisti, M, Demichelis, B, Febo, O, Forni, G, Riccardi, R, Riccardi, PG, Capomolla, S, Cobelli, F & Tavazzi, L 1998, 'Peak exercise oxygen consumption in chronic heart failure: Toward efficient use in the individual patient', Journal of the American College of Cardiology, vol. 31, no. 4, pp. 766-775. https://doi.org/10.1016/S0735-1097(98)00002-3
Opasich, Cristina ; Pinna, Gian Domenico ; Bobbio, Marco ; Sisti, Massimo ; Demichelis, Brunella ; Febo, Oreste ; Forni, Giovanni ; Riccardi, Roberto ; Riccardi, P. Giorgio ; Capomolla, Soccorso ; Cobelli, Franco ; Tavazzi, Luigi. / Peak exercise oxygen consumption in chronic heart failure : Toward efficient use in the individual patient. In: Journal of the American College of Cardiology. 1998 ; Vol. 31, No. 4. pp. 766-775.
@article{fbb306de095c41e18c394ba96d59945c,
title = "Peak exercise oxygen consumption in chronic heart failure: Toward efficient use in the individual patient",
abstract = "Objectives. This study sought to 1) assess the short-, medium- and long- term prognostic power of peak oxygen consumption (V̇O2) in patients with heart failure; 2) verify the consistency of a nonmeasurable anaerobic threshold (AT) as a criterion of nonapplicability of peak V̇O2; 3) develop simple rules for the efficient use of peak V̇O2 in individualized prognostic stratification and clinical decision making. Background. Peak V̇O2, when AT is identified, is among the indicators for heart transplant eligibility. However, in clinical practice the application of defined peak V̇O2 cutoff values to all patients could be inappropriate and misleading. Methods. Six hundred fifty-three patients consecutively considered for eligibility for heart transplantation were followed up. Outcomes (cardiac death and urgent transplantation) were determined when all survivors had a minimum of 6 months of follow-up. Results. Contraindication to the exercise test identified very high risk patients. The relatively small sample of women did not allow inferences to be drawn. In men, peak V̇O2 stratified into three levels (≤10, 10 to 18 and >18 ml/kg per min) identified groups at high, medium and low risk, respectively. The prognostic power of peak V̇O2 ≤10 ml/kg per min was maintained even when the AT was not detected. In patients in New York Heart Association functional class III or IV, peak V̇O2 did not have prognostic power. In patients in functional class I or II, peak V̇O2 stratification was prognostically valuable, but less so at 6 than at 12 or 24 months. Age did not influence peak V̇O2 prognostic stratification. Conclusions. A contraindication to exercise testing should be considered a priority for listing patients for heart transplantation. Only in less symptomatic male patients does a peak V̇O2 ≤10 ml/kg per min identify short-, medium- and long-term high risk groups. A peak V̇O2 >18 ml/kg per min implies good prognosis with medical therapy.",
author = "Cristina Opasich and Pinna, {Gian Domenico} and Marco Bobbio and Massimo Sisti and Brunella Demichelis and Oreste Febo and Giovanni Forni and Roberto Riccardi and Riccardi, {P. Giorgio} and Soccorso Capomolla and Franco Cobelli and Luigi Tavazzi",
year = "1998",
month = "3",
day = "15",
doi = "10.1016/S0735-1097(98)00002-3",
language = "English",
volume = "31",
pages = "766--775",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Peak exercise oxygen consumption in chronic heart failure

T2 - Toward efficient use in the individual patient

AU - Opasich, Cristina

AU - Pinna, Gian Domenico

AU - Bobbio, Marco

AU - Sisti, Massimo

AU - Demichelis, Brunella

AU - Febo, Oreste

AU - Forni, Giovanni

AU - Riccardi, Roberto

AU - Riccardi, P. Giorgio

AU - Capomolla, Soccorso

AU - Cobelli, Franco

AU - Tavazzi, Luigi

PY - 1998/3/15

Y1 - 1998/3/15

N2 - Objectives. This study sought to 1) assess the short-, medium- and long- term prognostic power of peak oxygen consumption (V̇O2) in patients with heart failure; 2) verify the consistency of a nonmeasurable anaerobic threshold (AT) as a criterion of nonapplicability of peak V̇O2; 3) develop simple rules for the efficient use of peak V̇O2 in individualized prognostic stratification and clinical decision making. Background. Peak V̇O2, when AT is identified, is among the indicators for heart transplant eligibility. However, in clinical practice the application of defined peak V̇O2 cutoff values to all patients could be inappropriate and misleading. Methods. Six hundred fifty-three patients consecutively considered for eligibility for heart transplantation were followed up. Outcomes (cardiac death and urgent transplantation) were determined when all survivors had a minimum of 6 months of follow-up. Results. Contraindication to the exercise test identified very high risk patients. The relatively small sample of women did not allow inferences to be drawn. In men, peak V̇O2 stratified into three levels (≤10, 10 to 18 and >18 ml/kg per min) identified groups at high, medium and low risk, respectively. The prognostic power of peak V̇O2 ≤10 ml/kg per min was maintained even when the AT was not detected. In patients in New York Heart Association functional class III or IV, peak V̇O2 did not have prognostic power. In patients in functional class I or II, peak V̇O2 stratification was prognostically valuable, but less so at 6 than at 12 or 24 months. Age did not influence peak V̇O2 prognostic stratification. Conclusions. A contraindication to exercise testing should be considered a priority for listing patients for heart transplantation. Only in less symptomatic male patients does a peak V̇O2 ≤10 ml/kg per min identify short-, medium- and long-term high risk groups. A peak V̇O2 >18 ml/kg per min implies good prognosis with medical therapy.

AB - Objectives. This study sought to 1) assess the short-, medium- and long- term prognostic power of peak oxygen consumption (V̇O2) in patients with heart failure; 2) verify the consistency of a nonmeasurable anaerobic threshold (AT) as a criterion of nonapplicability of peak V̇O2; 3) develop simple rules for the efficient use of peak V̇O2 in individualized prognostic stratification and clinical decision making. Background. Peak V̇O2, when AT is identified, is among the indicators for heart transplant eligibility. However, in clinical practice the application of defined peak V̇O2 cutoff values to all patients could be inappropriate and misleading. Methods. Six hundred fifty-three patients consecutively considered for eligibility for heart transplantation were followed up. Outcomes (cardiac death and urgent transplantation) were determined when all survivors had a minimum of 6 months of follow-up. Results. Contraindication to the exercise test identified very high risk patients. The relatively small sample of women did not allow inferences to be drawn. In men, peak V̇O2 stratified into three levels (≤10, 10 to 18 and >18 ml/kg per min) identified groups at high, medium and low risk, respectively. The prognostic power of peak V̇O2 ≤10 ml/kg per min was maintained even when the AT was not detected. In patients in New York Heart Association functional class III or IV, peak V̇O2 did not have prognostic power. In patients in functional class I or II, peak V̇O2 stratification was prognostically valuable, but less so at 6 than at 12 or 24 months. Age did not influence peak V̇O2 prognostic stratification. Conclusions. A contraindication to exercise testing should be considered a priority for listing patients for heart transplantation. Only in less symptomatic male patients does a peak V̇O2 ≤10 ml/kg per min identify short-, medium- and long-term high risk groups. A peak V̇O2 >18 ml/kg per min implies good prognosis with medical therapy.

UR - http://www.scopus.com/inward/record.url?scp=0032520998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032520998&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(98)00002-3

DO - 10.1016/S0735-1097(98)00002-3

M3 - Article

C2 - 9525544

AN - SCOPUS:0032520998

VL - 31

SP - 766

EP - 775

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -